Format

Send to

Choose Destination
Oncotarget. 2018 Aug 17;9(64):32276-32277. doi: 10.18632/oncotarget.25971. eCollection 2018 Aug 17.

Disabling an oncogenic transcription factor by targeting of control kinases.

Author information

1
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
2
Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

KEYWORDS:

kinase; leukemia; therapy; transcription factor

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center